Targeted delivery to bone and mineral deposits using bisphosphonate ligands

Area of Science:

• Biomedical Engineering
• Pharmacology
• Materials Science

Background:

• Bone and pathological calcifications possess unique mineral concentrations, enabling targeted drug delivery.
• Bisphosphonates (BPs) are established bone-targeting ligands with high affinity for hydroxyapatite mineral.
• BPs can be conjugated to therapeutic or imaging agents to direct them to specific sites.

Purpose of the Study:

• To review the current applications of bisphosphonates (BPs) as ligands for targeted delivery to bone and mineral deposits.
• To summarize the clinical history, binding mechanisms, and affinity of BPs.
• To highlight research on BP conjugates for therapy, imaging, and radiotherapy.

Main Methods:

• Literature review of bisphosphonate (BP) applications in targeted delivery.
• Summary of BP binding mechanisms and affinity measurement techniques (in vitro and in vivo).
• Highlighting current research on BP conjugates for various medical applications.

Main Results:

• Bisphosphonates (BPs) demonstrate significant potential for targeted delivery of therapeutics and imaging agents to bone and calcifications.
• BP conjugates are being explored for treating metabolic bone diseases, bone cancer, and other bone conditions.
• BP-based imaging probes show promise for scintigraphy, PET, MRI, and CT, while BP conjugates are also investigated for radiotherapy.

Conclusions:

• Bisphosphonates (BPs) are versatile ligands for targeted delivery, offering significant therapeutic and diagnostic opportunities.
• Understanding structure-function relationships is crucial for designing effective BP-drug conjugates.
• Further research into BP conjugates can advance treatments for bone diseases and improve diagnostic imaging.